The North West Fund for Biomedical has invested £550,000 in TTS Pharma, a UK-based developer of personalised nicotine patches for smokers.
Deal comes a year after Nordic Capital acquired Signicat from Viking Ventures
Fund is larger than its predecessor, Impresa Italia Private Debt I, which raised €70m in 2016
Data software company was valued at $1bn post money in its 2019 round and is now valued at $2.3bn
FVS invests for minority stakes in Italian companies operating in a wide range of sectors